The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poëa-Guyon, S.
Right arrow Articles by Berrih-Aknin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poëa-Guyon, S.
Right arrow Articles by Berrih-Aknin, S.
The Journal of Immunology, 2005, 174: 5941-5949.
Copyright © 2005 by The American Association of Immunologists

Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis 1

Sandrine Poëa-Guyon*, Premkumar Christadoss{dagger}, Rozen Le Panse*, Thierry Guyon2,*, Marc De Baets{ddagger}, Abdelilah Wakkach3,*, Jocelyne Bidault*, Socrates Tzartos§ and Sonia Berrih-Aknin4,*

* Unité Mixte de Recherche 8078, Centre National de la Recherche Scientifique/Université Paris Sod, Institut Paris Sod Cytokines, Hôpital Marie Lannelongue, Le Plessis-Robinson, France; {dagger} Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555; {ddagger} Department of Neurology, University of Maastricht, Maastricht, The Netherlands; and § Department of Pharmacy, University of Patras, Patras, Greece

Myasthenia gravis is an autoimmune disease associated with thymic pathologies, including hyperplasia. In this study, we investigated the processes that may lead to thymic overexpression of the triggering Ag, the acetylcholine receptor (AChR). Using microarray technology, we found that IFN-regulated genes are more highly expressed in these pathological thymic tissues compared with age- and sex-matched normal thymus controls. Therefore, we investigated whether proinflammatory cytokines could locally modify AChR expression in myoid and thymic epithelial cells. We found that AChR transcripts are up-regulated by IFN-{gamma}, and even more so by IFN-{gamma} and TNF-{alpha}, as assessed by real-time RT-PCR, with the {alpha}-AChR subunit being the most sensitive to this regulation. The expression of AChR protein was increased at the cytoplasmic level in thymic epithelial cells and at the membrane in myoid cells. To examine whether IFN-{gamma} could influence AChR expression in vivo, we analyzed AChR transcripts in IFN-{gamma} gene knock-out mice, and found a significant decrease in AChR transcript levels in the thymus but not in the muscle, compared with wild-type mice. However, up-regulation of AChR protein expression was found in the muscles of animals with myasthenic symptoms treated with TNF-{alpha}. Altogether, these results indicate that proinflammatory cytokines influence the expression of AChR in vitro and in vivo. Because proinflammatory cytokine activity is evidenced in the thymus of myasthenia gravis patients, it could influence AChR expression and thereby contribute to the initiation of the autoimmune anti-AChR response.




This article has been cited by other articles:


Home page
BloodHome page
A. Gilboa-Geffen, P. P. Lacoste, L. Soreq, G. Cizeron-Clairac, R. Le Panse, F. Truffault, I. Shaked, H. Soreq, and S. Berrih-Aknin
The thymic theme of acetylcholinesterase splice variants in myasthenia gravis
Blood, May 15, 2007; 109(10): 4383 - 4391.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Le Panse, G. Cizeron-Clairac, J. Bismuth, and S. Berrih-Aknin
Microarrays Reveal Distinct Gene Signatures in the Thymus of Seropositive and Seronegative Myasthenia Gravis Patients and the Role of CC Chemokine Ligand 21 in Thymic Hyperplasia
J. Immunol., December 1, 2006; 177(11): 7868 - 7879.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Meraouna, G. Cizeron-Clairac, R. L. Panse, J. Bismuth, F. Truffault, C. Tallaksen, and S. Berrih-Aknin
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Blood, July 15, 2006; 108(2): 432 - 440.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.